Santa Cruz Biotechnology features a diverse variety of E. coli K99 monoclonal antibodies for research in understanding this important bacterial protein. E. coli K99 Antibodies are highly useful in various techniques, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). E. coli K99 is a fimbrial adhesin that plays a crucial role in the attachment of pathogenic E. coli strains to the intestinal epithelium of neonatal animals, leading to diarrhea and other gastrointestinal diseases. Understanding the function of E. coli K99 is vital for developing strategies to combat infections caused by this pathogen, particularly in livestock and veterinary medicine. The study of E. coli K99 can provide insights into bacterial adhesion mechanisms, which are relevant to broader microbiological research. Researchers worldwide rely on E. coli K99 monoclonal antibodies for investigating host-pathogen interactions and developing new therapeutic approaches. Current investigations focus on understanding the molecular basis of E. coli K99-mediated adhesion and its role in disease progression. Santa Cruz Biotechnology monoclonal antibodies enable researchers to advance scientific understanding of bacterial pathogenesis and contribute to the development of innovative treatments for E. coli infections.